BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3318975)

  • 1. Mathematical model of Klebsiella pneumoniae resistance to amikacin and gentamicin.
    Nicolelis MA; Massad E; Hutzler RU; Engel A; Rodrigues E; Bazzone JC; Tomida M
    Braz J Med Biol Res; 1987; 20(1):35-41. PubMed ID: 3318975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepant susceptibility to gentamicin despite amikacin resistance in Klebsiella pneumoniae by VITEK 2 represents false susceptibility associated with the armA 16S rRNA methylase gene.
    Ko JH; Baek JY; Peck KR; Cho SY; Ha YE; Kim SH; Huh HJ; Lee NY; Kang CI; Chung DR; Song JH
    J Med Microbiol; 2017 Oct; 66(10):1448-1450. PubMed ID: 28893358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activity of amikacin and gentamicin.
    Shah RM; Heetderks G; Stille W
    Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in serum sensitivity and hydrophobicity in a clinical isolate of Klebsiella pneumoniae treated with subinhibitory concentrations of aminoglycosides.
    Hostacká A
    Zentralbl Bakteriol; 1998 Dec; 288(4):519-26. PubMed ID: 9987190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin and amikacin.
    Hostacká A
    J Basic Microbiol; 1998; 38(5-6):383-8. PubMed ID: 9871334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to gentamicin and amikacin of gram-negative organisms isolated from horses.
    Orsini JA; Benson CE; Spencer PA; Van Miller E
    Am J Vet Res; 1989 Jun; 50(6):923-5. PubMed ID: 2669575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activity of amikacin towards gentamicin-resistant, Gram-negative bacilli].
    Nicoletti G; Russo G; Toscano MA; Gismondo MR
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):713-7. PubMed ID: 121911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.
    Hamory B; Ignatiadis P; Sande MA
    JAMA; 1976 Oct; 236(17):1973-4. PubMed ID: 787564
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
    Sekowska A; Janicka G; Kłyszejko C; Wojda M; Wróblewski M; Szymankiewicz M
    Med Sci Monit; 2002 Mar; 8(3):BR100-4. PubMed ID: 11889457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacterial resistance in clinical isolates of Klebsiella pneumoniae].
    Wang YQ; Wang F; Zhu DM
    Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):88-91, 126. PubMed ID: 7767775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro.
    Caulin E; Coutrot A; Carbon C; Collatz E
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2848-53. PubMed ID: 9124853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-antibiotic effect of three aminoglycosides against Klebsiella pneumoniae].
    de Montclos M; Guinet M; Chapuis C; Flandrois JP
    Pathol Biol (Paris); 1994 May; 42(5):419-24. PubMed ID: 7824306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of Amikacin (BB-K8) and gentamicin activity in vitro against Proteus rettgeri.
    Pérez-Rodríguez F; Bermúdez RH; de Brau CJ
    Bol Asoc Med P R; 1977 Jul; 69(7):222-6. PubMed ID: 268183
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistant rate to antibiotics in Tian Tan Hospital for 3 years].
    Song JF; Tang MZ; Wang MR
    Zhonghua Nei Ke Za Zhi; 1992 Sep; 31(9):556-8, 587. PubMed ID: 1303851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and microbiologic consequences of amikacin use during a 42-month period.
    Berk SL; Alvarez S; Ortega G; Verghese A; Holtsclaw-Berk SA
    Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae.
    Naparstek L; Carmeli Y; Navon-Venezia S; Banin E
    J Antimicrob Chemother; 2014 Apr; 69(4):1027-34. PubMed ID: 24408988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning of amikacin resistance determinants from a Klebsiella pneumoniae plasmid.
    Tolmasky ME; Roberts M; Woloj M; Crosa JH
    Antimicrob Agents Chemother; 1986 Aug; 30(2):315-20. PubMed ID: 3021052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.